Matches in Wikidata for { <http://www.wikidata.org/entity/Q57213375> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q57213375 description "article scientifique publié en 2012" @default.
- Q57213375 description "im Mai 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57213375 description "wetenschappelijk artikel" @default.
- Q57213375 description "наукова стаття, опублікована в травні 2012" @default.
- Q57213375 name "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 name "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 type Item @default.
- Q57213375 label "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 label "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 prefLabel "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 prefLabel "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 P1433 Q57213375-21752873-C471-4CC5-935C-48AF698E4EF6 @default.
- Q57213375 P1476 Q57213375-628D8CD1-63EB-4EF9-A566-CF3FAAD0A3A6 @default.
- Q57213375 P2093 Q57213375-461A758D-793B-4858-B22A-C90AB12483A0 @default.
- Q57213375 P2093 Q57213375-5AB3B7F9-D553-477F-B9B4-18A5F8DCACDE @default.
- Q57213375 P2093 Q57213375-8F90BAFD-A6AC-4F91-B327-F37BD928A7CC @default.
- Q57213375 P2093 Q57213375-C369EDC1-EF6E-452F-8206-337DCD2B023D @default.
- Q57213375 P2860 Q57213375-1DA2B3DB-AD5C-4A1D-A00A-E13155F0675B @default.
- Q57213375 P2860 Q57213375-2BDD8713-06F4-4496-B1F1-7B8A791481B3 @default.
- Q57213375 P2860 Q57213375-3142EFDA-8773-423E-A29A-800E049AB5AF @default.
- Q57213375 P2860 Q57213375-3341232A-5320-4C64-A6E4-C86688131E06 @default.
- Q57213375 P2860 Q57213375-7665D64B-8F66-42CF-B6FA-C4ED1B14CEFE @default.
- Q57213375 P2860 Q57213375-8D0BC9BB-F047-4915-AAF7-BE8D03DB8EBB @default.
- Q57213375 P2860 Q57213375-A57948FE-2C08-48D2-A619-0461665B5C01 @default.
- Q57213375 P2860 Q57213375-CDDD07AE-A978-4E79-BE52-1A8481252627 @default.
- Q57213375 P2860 Q57213375-DB740C49-BC8E-4538-972B-7D75B2130A00 @default.
- Q57213375 P2860 Q57213375-E789F147-99B2-41DD-866C-8D034021722F @default.
- Q57213375 P2860 Q57213375-EF1A4C34-432B-434D-846C-CACA3324D22F @default.
- Q57213375 P304 Q57213375-98FC3C45-FB7B-42D5-8BCC-4865ECE24B6C @default.
- Q57213375 P31 Q57213375-89E93AAC-9B73-462C-9028-44ABB116CD96 @default.
- Q57213375 P356 Q57213375-FC9D5545-521B-490E-83F5-25F0244C6912 @default.
- Q57213375 P407 Q57213375-4F378E18-72BD-46BE-8740-EED6A19C91D9 @default.
- Q57213375 P433 Q57213375-95E3F789-AC79-4CED-B83B-F3870DC866D3 @default.
- Q57213375 P478 Q57213375-C169D697-C345-4EA7-98E6-85148EB43A3D @default.
- Q57213375 P50 Q57213375-2F0281EB-2441-4373-A707-6F960D74DE95 @default.
- Q57213375 P50 Q57213375-C494FD84-3268-4490-90E6-240B2A57FA91 @default.
- Q57213375 P50 Q57213375-E3CA4838-22F3-4578-A3A7-AB48A7516B39 @default.
- Q57213375 P577 Q57213375-33F94C2D-3CEB-46E9-A0E8-220EED78E495 @default.
- Q57213375 P698 Q57213375-7DBB70F2-0328-48CB-9014-605F36FE7440 @default.
- Q57213375 P921 Q57213375-A1BB99D0-EA60-4954-A888-F067E6FC481C @default.
- Q57213375 P921 Q57213375-E1000B2B-1673-4495-BEE2-569D0D733363 @default.
- Q57213375 P356 J.1600-0609.2012.01772.X @default.
- Q57213375 P698 22404151 @default.
- Q57213375 P1433 Q15765799 @default.
- Q57213375 P1476 "The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights" @default.
- Q57213375 P2093 "Angel Santos-Briz" @default.
- Q57213375 P2093 "Concepción Román" @default.
- Q57213375 P2093 "Javier Cañueto" @default.
- Q57213375 P2093 "Teresa Contreras" @default.
- Q57213375 P2860 Q31928232 @default.
- Q57213375 P2860 Q35064390 @default.
- Q57213375 P2860 Q35849268 @default.
- Q57213375 P2860 Q36516158 @default.
- Q57213375 P2860 Q37835571 @default.
- Q57213375 P2860 Q46523985 @default.
- Q57213375 P2860 Q46543501 @default.
- Q57213375 P2860 Q46549268 @default.
- Q57213375 P2860 Q47708804 @default.
- Q57213375 P2860 Q57255909 @default.
- Q57213375 P2860 Q57904604 @default.
- Q57213375 P304 "450-4" @default.
- Q57213375 P31 Q13442814 @default.
- Q57213375 P356 "10.1111/J.1600-0609.2012.01772.X" @default.
- Q57213375 P407 Q1860 @default.
- Q57213375 P433 "5" @default.
- Q57213375 P478 "88" @default.
- Q57213375 P50 Q117264993 @default.
- Q57213375 P50 Q37830539 @default.
- Q57213375 P50 Q39399978 @default.
- Q57213375 P577 "2012-05-01T00:00:00Z" @default.
- Q57213375 P698 "22404151" @default.
- Q57213375 P921 Q422252 @default.
- Q57213375 P921 Q929833 @default.